Late course accelerated hyperfractionated radiotherapy of nasopharyngeal carcinoma (LCAF)

Radiotherapy and Oncology

Volumn 85, Issue 1, 2007, Pages 29-35

  He, Xia yun ^a   Liu, Tai fu ^a   He, Shao qin ^a   Huan, Su lan ^a   Pan, Zi qiang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Accelerated fractionation; Hyperfractionation; Nasopharyngeal carcinoma; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; COBALT 60;

ADULT; AGED; ARTICLE; BRAIN DAMAGE; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; RADIATION BEAM; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; XEROSTOMIA; ADOLESCENT; MIDDLE AGED; MORTALITY; NASOPHARYNX TUMOR; PHASE 2 CLINICAL TRIAL; RADIOTHERAPY;

ADOLESCENT; ADULT; AGED; DOSE FRACTIONATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RADIOTHERAPY;

EID: 35248853384     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2007.08.005     Document Type: Article

References (30)

1. Lee S.W., Back G.M., Yi B.Y., et al. Preliminary results of a phase I/II study of simultaneous modulated accelerated radiotherapy for nondisseminated nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 152-160
2. Teo P.M., Leung S.F., Tung S.Y., et al. Dose-response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG). Radiother Oncol 79 (2006) 27-33
3. Kajanti M., Blomqvist C., Lehtonen H., et al. Biweekly dose escalation in curative accelerated hyperfractionation for advanced head and neck cancer: a feasibility study. Int J Radiat Oncol Biol Phys 39 (1997) 837-840
4. Ang K.K. Altered fractionation trials in head and neck cancer. Semin Radiat Oncol 8 (1998) 230-236
5. Lindholm P., Valavaara R., Aitasalo K., et al. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study. Radiother Oncol 78 (2006) 146-151
6. Withers H.R., Taylor J.M., and Maciejewski B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol 27 (1988) 131-146
7. Hu C., Huan S., Zhang Y., et al. Hyperfractionated radiotherapy of nasopharyngeal carcinoma with concomitant boost: a prospective randomized trial. Chin J Radiat Oncol 7 (1998) 93-96
8. Cox J.D., Stetz J., Pajak T.F., et al. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
9. LENT SOMA tables. Radiother Oncol 1995; 35:17-60.
10. YI J.L., Gao L., Huang X.D., et al. Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institution. Int J Radiat Oncol Biol Phys 65 (2006) 161-168
11. Chua D.T., Sham J.S., Kwong D.L., et al. Treatment outcome after radiotherapy alone for patients with stage I-II nasopharyngeal carcinoma. Cancer 98 (2003) 74-80
12. Lee N., Xia P., Quivey J.M., et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53 (2002) 12-22
13. Kam M.K., Teo P.M., Chau R.M., et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 60 (2004) 1440-1450
14. Cummings B.J. Benefits of accelerated hyperfractionation for head and neck cancer. Acta Oncol 38 (1999) 131-136
15. Wang C.C. Accelerated hyperfractionation radiotherapy for cancer of the nasopharynx. Techniques and results. Cancer 63 (1989) 2461-2467
16. Lee A.W., Poon Y.F., Foo W., et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985; overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 23 (1992) 261-270
17. Teo P.M., Leung S.F., Chan A.T., et al. Final report of a randomized trial on altered-fractionated radiotherapy in nasopharyngeal carcinoma prematurely terminated by significant increase in neurologic complications. Int J Radiat Oncol Biol Phys 48 (2000) 1311-1322
18. Shi X.H. Esophageal carcinoma. In: Taifu L. (Ed). Modern radiation oncology (2001), Fudan University Press, Shanghai, China
19. Zhang Y.W., and Miao Y.Y. Nasopharyngeal carcinoma. In: Zhaoyou T. (Ed). Modern oncology (2000), Fudan University Press, Shanghai, China
20. Lin J.C., Chen K.Y., Jan J.S., et al. Partially hyperfractionated accelerated radiotherapy and concurrent chemotherapy for advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 36 (1996) 1127-1136
21. Kong L., Zhang Y.W., Wu Y.R., et al. Late side reactions of long-term survivors after radiotherapy for nasopharyngeal carcinoma. Chin J Radiat Oncol 15 (2006) 151-156
22. Yeh S.A., Tang Y., Lui C.C., et al. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 62 (2005) 672-679
23. Fu K.K., Pajak T.F., Trotti A., et al. A radiation therapy oncology group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 48 (2000) 7-16
24. Lee A.W., Law S.C., Ng S.H., et al. Retrospective analysis nasopharyngeal carcinoma treated during 1976-1985: late complications following megavoltage irradiation. Br J Radio 65 (1992) 918-928
25. Flores A.D., Dickson R.I., Riding K., et al. Cancer of the nasopharynx in British Columbia. Am J Clin Oncol 9 (1986) 281-291
26. Al-Sarraf M., LeBlanc M., Giri P.G., et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III Randomized Intergroup Study 0099. J Clin Oncol 16 (1998) 1310-1317
27. Teo P.M., Chan A.T., Lee W.Y., et al. Enhancement of local control in locally advanced node-positive nasopharyngeal carcinoma by adjunctive chemotherapy. Int J Radiat Oncol Biol Phys 43 (1999) 261-271
28. Zhao K.L., Shi X.H., Jiang G.L., et al. Late course accelerated hyperfractionated radiotherapy plus concurrent chemotherapy for squamous cell carcinoma of the esophagus: a phase III randomized study. Int J Radiat Oncol Biol Phys 62 (2005) 1014-1020
29. Arcangeli G., Saracino B., Danesi D.T., et al. Accelerated hyperfractionated radiotherapy and concurrent protracted venous infusion chemotherapy in locally advanced head and neck cancer. Am J Clin Oncol 25 (2002) 431-437
30. Ishii K., Tashiro M., Hosono M., et al. Accelerated hyperfractionated irradiation with concomitant boost for stage II laryngeal cancer and locally advanced head and neck cancer. Acta Otolaryngol Suppl 554 (2004) 62-66